PLAZENTA-WACHSTUMSFAKTOR ALS TARGET FÜR DIE BEHANDLUNG VON OSTEOPOROSE

摘要

This invention relates to antagonists of placental growth factor and signalling thereof, pharmaceutical compositions containing such antagonists and the use of such antagonists to prevent bone loss or bone mass and to enhance bone healing including the treatment of conditions which present with low bone mass and/or bone defects in vertebrates, and particularly mammals, including humans.